Dr. Michael S. Lee, MD

  • Houston, TX
  • Hematologist and oncologist
NPI1952539108
Medicare services, 2023
237
Part D claims, 2023
75
Publications
30
Clinical trials
4
MIPS score, 2024
84
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Lee's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael S. Lee is a hematologist and oncologist in Houston, Texas

Dr. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Lee's NPI, 1952539108, was assigned on June 26, 2009. Dr. Lee graduated from Duke University School Of Medicine in 2009. Dr. Lee holds Texas license S5966.

NPI and contact details
NPI enumeration date
June 26, 2009
NPI status
Active
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
43
Medical school graduation
2009

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Michael S. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Source: Dmand AI Affiliation Data

Dr. Michael S. Lee is affiliated with 1 site of care

Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael S. Lee's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lee practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael S. Lee is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lee is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 11 states: Texas, Florida, Arizona, Tennessee, Washington, Georgia, Louisiana, Mississippi, Oklahoma, Alabama and North Carolina.

Specialties and state licenses

  • Hematology and oncology, TexasPrimaryLicense S5966 · 2020 to 2026 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • Arizona license2023 to 2025
  • Tennessee license2023 to 2025
  • Washington license2023 to 2025
  • Georgia license2023 to 2024
  • Louisiana license2023 to 2024
  • Mississippi license2023 to 2024
  • Oklahoma license2023 to 2024
  • Alabama license2023
  • North Carolina licenseLicense 2015-01422 · 2015 to 2021

Clinical focus

Dmand AI lists colorectal cancer, fluid and electrolyte imbalances and prostate cancer among the conditions Dr. Lee treats.

Hematologists and oncologists near Dr. Lee

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael S. Lee billed Medicare for 237 services in 2023

CMS data shows 237 Medicare services from Dr. Lee across 4 procedure codes in 2023, all of them office visits. Medicare paid $23,353 for them.

Medicare services, 2023237
Paid by Medicare$23,353
Procedure codes4

Dr. Lee's Medicare services by type, 2022 to 2023

  • 2022
  • 2023
Office and hospital visits
2022: 2962023: 23720%

Where Dr. Lee's Medicare services took place, 2023

  • In an office6226%
  • In a facility17574%

Dr. Lee compared with the Texas median for hematologists and oncologists, 2023

  • Dr. Lee
  • Texas median
Medicare services
237vs 1,16280% below
Part D claims
75vs 48985% below

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Lee's most billed Medicare procedure codes, 2023

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lee

Need commercial claims for Dr. Lee?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lee and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael S. Lee's patients have a median age of 45

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 45, with 50% women.

Dr. Lee's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 45

Patient panel by sex, all payers

  • Women50%
  • Men50%

Source: Dmand AI Patient Panel Data

Dr. Michael S. Lee wrote 75 Medicare Part D claims in 2023

In 2023, Dr. Lee wrote 75 Medicare Part D claims. They cover 4 drugs, with $31,120 in total drug cost. In 2022, CMS named 126 claims across 5 drugs.

Part D claims, 202375
Drugs named by CMS4
Total drug cost$31,120

Dr. Lee's most prescribed drugs by claims, 2023

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2022 to 2023

  • 2022
  • 2023
Claims for drugs CMS names
2022: 1262023: 7540%

Drugs named by CMS: 4 in 2023, 5 in 2022.

See all prescribing by Dr. Lee

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

Dr. Michael S. Lee scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lee for performance year 2024, reported as part of a group.

Dr. Lee's MIPS scores, performance year 2024

  • 84of 100Final score
  • 70.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 68of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lee by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael S. Lee has 30 publications on record

Dmand AI links 30 papers to Dr. Lee, published from 2013 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Biomarkers, Tumor. Dr. Lee has published most often in Oncologist. Dr. Lee's most frequent co-authors are Michael J. Overman, MD, Shubham Pant, MD and Hanna K. Sanoff, MD.

Papers30
Years published2013 to 2025

Dr. Lee's papers by year, 2013 to 2025

Topics Dr. Lee writes about most

  • Colorectal Neoplasms
  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • DNA Methylation
  • Microsatellite Instability
  • Camptothecin
  • CpG Islands
  • Genomics

Dr. Lee's most frequent co-authors

Recent publications by Dr. Lee

See all 30 publications and co-authors

See who Dr. Lee researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lee works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael S. Lee has worked on 4 clinical trials

Dmand AI links Dr. Lee to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Colonic Neoplasms, Colorectal Neoplasms and Adenocarcinoma Of Esophagus. UNC Lineberger Comprehensive Cancer Center sponsors the most, 2. Open Payments lists research payments to Dr. Lee that name 1 trial.

Conditions in Dr. Lee's trials

  • Colonic Neoplasms
  • Colorectal Neoplasms
  • Adenocarcinoma Of Esophagus
  • Neoplasms, Squamous Cell
  • Neoplasm Metastasis

Investigators on the most trials with Dr. Lee

Recent clinical trials with Dr. Lee

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Michael S. Lee received $45,374 in industry payments from 2016 to 2023

CMS Open Payments shows 64 general payments to Dr. Lee from 11 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 35% of the total. Genentech, Inc. paid the most, $32,576. It also lists 8 research payments totaling $10,875 from 2020 to 2021, naming 1 clinical trial.

General payments to Dr. Lee by program year, 2016 to 2023

General payments to Dr. Lee by kind, 2016 to 2023

$45.4Kin total
  • Speaker and faculty fees$15,75635%
  • Travel and lodging$13,95531%
  • Consulting fees$11,14425%
  • Food and beverage$2,5206%
  • Honoraria$2,0004%

Companies that paid Dr. Lee the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Lee

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Michael S. Lee graduated from Duke University School Of Medicine

Dr. Lee graduated from Duke University School Of Medicine in 2009.

  1. Medical schoolDuke University School Of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Michael S. Lee accepts plans from 5 insurance carriers

Dr. Lee is in network with 5 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • Elevance
  • Blue Cross Blue Shield of Michigan
  • Blue Cross Blue Shield of Massachusetts
  • Arkansas Blue Cross and Blue Shield

Plan types Dr. Lee accepts, by number of carriers

  1. PPO5
  2. Medicare4
  3. POS3
  4. EPO2
  5. HMO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Michael S. Lee's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesClinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael S. Lee

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael S. Lee's NPI number?

Dr. Michael S. Lee's NPI number is 1952539108. It was assigned on June 26, 2009, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael S. Lee?

Dr. Michael S. Lee is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Michael S. Lee practice?

Dr. Lee practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Lee's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

What is Dr. Michael S. Lee's medical license number?

Dr. Lee holds Texas license S5966, one of the licenses on file in 11 states.

Which states has Dr. Michael S. Lee been licensed in?

Dmand AI has state licenses on file for Dr. Lee in Texas (2020 to 2026), Florida (since 2021), Arizona (2023 to 2025), Tennessee (2023 to 2025), Washington (2023 to 2025), Georgia (2023 to 2024), Louisiana (2023 to 2024), Mississippi (2023 to 2024), Oklahoma (2023 to 2024), Alabama (2023) and North Carolina (2015 to 2021).

Which hospitals is Dr. Michael S. Lee affiliated with?

Dr. Lee practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Does Dr. Michael S. Lee accept Medicare?

Yes. CMS data shows Dr. Lee billed Medicare for 237 services in 2023.

What is Dr. Michael S. Lee's MIPS score?

Dr. Lee's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Is Dr. Michael S. Lee board certified?

Yes. Dr. Lee is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Michael S. Lee bill to Medicare?

In 2023, Dr. Lee's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, new patient (99205).

Show 7 more questionsShow fewer questions

Where did Dr. Michael S. Lee go to medical school?

Dr. Lee graduated from Duke University School Of Medicine in 2009.

What drugs does Dr. Michael S. Lee prescribe most?

In 2023 Medicare Part D data, Dr. Lee's most prescribed drugs by claims were Eliquis, Prochlorperazine Maleate and Creon.

Has Dr. Michael S. Lee received payments from drug or device companies?

CMS Open Payments shows $45,374 in general payments to Dr. Lee from 11 companies from 2016 to 2023. The largest total came from Genentech, Inc.

How long has Dr. Michael S. Lee been practicing?

Dr. Lee graduated from medical school in 2009, 17 years ago.

Does Dr. Michael S. Lee do research?

Dmand AI links 30 publications to Dr. Lee, published from 2013 to 2025. Dr. Lee has worked on 4 clinical trials.

Who does Dr. Michael S. Lee publish with?

Dr. Lee's most frequent co-authors are Michael J. Overman, MD (5 shared papers), Shubham Pant, MD (5 shared papers) and Hanna K. Sanoff, MD (5 shared papers).

What insurance does Dr. Michael S. Lee accept?

Dr. Lee is in network with 5 carriers, including Excellus BlueCross BlueShield, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)